Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone

NCT01512108 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

363

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: liraglutide
DRUG: oral anti-diabetic drug

Sponsor

Novo Nordisk A/S